Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Baqiyatallah Medical Sciences University |
---|---|
Information provided by: | Baqiyatallah Medical Sciences University |
ClinicalTrials.gov Identifier: | NCT00512811 |
to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure
Condition | Intervention | Phase |
---|---|---|
Bronchiolitis |
Drug: furosemide |
Phase III |
Study Type: | Interventional |
Study Design: | Supportive Care, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Crossover Assignment |
Official Title: | Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study |
Ages Eligible for Study: | 32 Years to 83 Years |
Genders Eligible for Study: | Male |
Inclusion Criteria:
Exclusion Criteria:
Iran, Islamic Republic of | |
RCCI | |
Tehran, Iran, Islamic Republic of |
Study Chair: | Mostafa Ghanei, MD | Research Center of Chemical Injuries, Baqiyatallah Medical Science University, Tehran, Iran |
Study ID Numbers: | 121a25 |
Study First Received: | August 7, 2007 |
Last Updated: | August 7, 2007 |
ClinicalTrials.gov Identifier: | NCT00512811 |
Health Authority: | Iran: Ethics Committee |
furosemide inhalation dyspnea spirometry |
mustard gas bronchiolitis sulfur mustard |
Mustard Gas Lung Diseases, Obstructive Respiratory Tract Infections Respiratory Tract Diseases Mechlorethamine |
Lung Diseases Bronchiolitis Bronchitis Furosemide Dyspnea |
Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Bronchial Diseases Natriuretic Agents Therapeutic Uses Physiological Effects of Drugs |
Diuretics Cardiovascular Agents Sodium Potassium Chloride Symporter Inhibitors Dermatologic Agents Pharmacologic Actions |